학술논문

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 and hepatitis B coinfection (ALLIANCE): a double-blind, multicentre, randomised controlled, phase 3 non-inferiority trial
Document Type
Article
Source
In The Lancet HIV October 2023 10(10):e640-e652
Subject
Primary Research
Articles
Language
ISSN
2352-3018